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The alkylating agent cyclophosphamide (Cy)  alters  (suppresses or enhances)  im- 
mune responses in vivo (1-5) but does not act on lymphocyte functions in vitro. The 
lack of in vitro effects of Ely is a result of the fact that Ely has to be metabolized into 
the  active compounds  which  are  formed by a  sequence of reactions catalyzed by 
microsomal enzymes in the liver (6).  It has been shown that  Ely activated by liver 
microsomes in vitro acts as an immunosuppressive in vitro (7).  4-hydroperoxycyclo- 
phosphamide (4HP-Ely) is a relatively stable derivative of Cy which is spontaneously 
converted in aqueous solution into 4-hydroxycyclophosphamide, the naturally occur- 
ring,  but  very unstable,  metabolite of Ely. Recently, it  has been  reported  (6)  that 
4HP-Ely acts like activated Ely immunosuppressive in vitro. In this report, we present 
results which show that  (a)  lymphocyte functions, as analyzed by their capacity to 
respond to mitogens in vitro can be influenced (enhanced or suppressed) by pretreat- 
ment of the cell donors in vivo by Cy or by treatment of the ceils in vitro with 4HP- 
Ely, and that (b) the enhancement of the mitogenic response of dextran sulfate-reactive 
B lymphocytes by Cy or 4HP-Ely is a result of functional inactiyation of T-suppressor 
cells by these drugs, and that  (c) B lymphocytes are less sensitive to Ely or 4HP-Cy 
action than this type of T-suppressor cell. 
Materials and Methods 
Animals.  Female C57BL/6J, (C57BL/6] × DBA 2)F1, BALB/c, and athymic nude (BALB/ 
c)  mice  were used at  8-10  wk of age.  The animals  were  obtained from Dr.  K.  Friis,  G1. 
Bomholdgard Ltd., Ry, Denmark. 
Chemicals and  Reagents.  Cy and  4HP-Cy were  generodsly  provided by the  Asta-Werke, 
Brockwede, Federal Republic of Germany. Dextran sulfate  (DS), mol wt 5 ×  105 from Serva 
Feinbiochemica, Heidelberg, Federal Republic of Germany; lipopolysaccharide  (LPS)  from 
Escherichia coli 0 55:B 5 from Difco Laboratories,  Detroit, Mich.; concanavalin A (Con A) from 
Calbioehem-Behring Corp., American Hoechst Corp., San Diego, Calif.; monoclonal anti-Thy- 
1.2 antibody from OLAC Ltd., Blackthorn,  Bicester, Oxon, England; guinea pig complement 
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(C) from Behring-Werke AG, Marburg/Lahn, Federal Republic of Germany; fetal calf serum 
(FCS), batch No. 104 from Seromed, Munich, Federal Republic of Germany; and RPMI-1640 
medium from Microbiological Associates,  Walkersville, Md. were used. 
Cell Suspensions.  Spleen cell and thymocyte suspensions were prepared in serum-free culture 
medium, as described earlier (8). 
Anti-Theta  Serum and Complement Treatment.  1 ×  10  v spleen  cells  were  incubated  at  room 
temperature  for 30 min with anti-Thy-l.2 antiserum  (final  dilution  1:3,000).  The cells were 
washed, resuspended at a concentration of 107"  m1-1 in agarose-adsorbed C (final  dilution  1:6) 
and kept for 60 min at 37°C. The cells were washed and resuspended at a concentration of 2 
×  106 viable cells  (as  determined  by the trypan  blue  dye exclusion  test)  per ml  in serum- 
supplemented culture medium. 
Treatment of the Cells by 4HP-Cy.  107 cells.m1-1  (suspended in serum-free culture medium) 
were incubated with various doses of  4HP-Cy )0.1-10/~g. m1-1) for 1 h at 37°C in an atmosphere 
of 5% CO2 in air. As determined by trypan blue dye exclusion test, 4HP-Cy treatment did not 
change viability of the cells. 
Cell Cultures and Determination of [SH]Thymidine  ([3H]TdR)  Uptake by the Cells.  Conditions for 
3  cell cultures and for determination of [ H]TdR uptake by the cells has been described in detail 
earlier  (9). Briefly,  cells  were cultured  in triplicates  in a  total  vol of 0.2  ml  (2  ×  106 cells. 
m1-1) in microtiter plates (M24AR, Greiner, Niirtingen, Federal Republic of Germany) in an 
atmosphere of 5% CO2 in air at 37°C for 2 or 4 d in RPMI-1640 medium supplemented with 
5% FCS, 5 X 10  -5 M 2-mercaptoethanol, 2 mM L-glutamine.ml-1; 100 U penicillin.ml -I, and 
100/~g.m1-1 streptomycin. 0.1 /~Ci of [3H]TdR (sp act:  2 Ci.mM -1, Radioehemical Centre, 
Amersham, England) was added to the cultures for the last 4 h of the incubation period. Cells 
were  collected  on  glass-fiber  filters  using  a  Skatron  multiple  cell  culture  collector  (Flow 
Laboratories,  Roekville,  Md.).  Incorporation of [3H]TdR  into  the  nuclear  DNA was  then 
determined as described previously (9). 
The results are expressed as A counts/minute per culture  (counts per minute in mitogen- 
treated culture -  counts per minute in control cultures) or as stimulation indices (counts per 
minute  in  mitogen-treated  cultures  per counts  per minute  in  control  culture).  Each  value 
represents the arithmetic mean of A counts per minute detected in triplicate cultures, SE was 
<10%. 
Results  and  Discussion 
Administraaion  of Cy, as a  rule,  results  in either immunosuppression,  or immune 
tolerance  (1).  However,  Cy  injected  several  days  before  antigen  administration 
paradoxically enhances T-cell-mediated, e.g., delayed type of hypersensitivity (DTH) 
(2), as well as humoral, e.g., to a synthetic antigen (3), immune responses. Suppression 
of antibody formation,  as well  as enhancement  of DTH  induction  by the drug has 
been originally attributed  to preferential  elimination of short-lived B lymphocytes in 
the  lymphoid organs  (2,  10).  Recently,  the enhancing effect of Cy on DTH  (4),  as 
well as on humoral  immune responses  (3),  has been attributed  to elimination  of T- 
suppressor cells. Along these lines, we presented results indicating that Cy-sensitive T- 
suppressor  cells  control  the  generation,  as  well  as  the  expression  of  activity  of 
autoreactive T  cells in vivo (5).  The results suggested that T-suppressor cells (or their 
precursors)  should be more sensitive to Cy treatment  in vivo than  B  lymphocytes or 
other T-cell subsets mediating various immunological activities. 
A  direct proof for these suggestions was lacking until now, because Cy does not act 
in vitro on lymphocytes. Recently, Shand and Howard (6)  showed that Cy activated 
with microsomal enzymes in vitro, as well as derivatives of Cy, e.g., 4HP-Cy, can be 
used for in vitro studies.  They reported that  B, as well  as T  lymphocytes treated  in 
vitro with either activated Cy or with 4HP-Cy transiently  lost their capacity to give 
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Fxo.  1.  The selective inhibition by 4HP-Cy-sensitive thymocytes of the DS response of spleen cells 
derived from Cy-injected mice. C57BL mice were injected with 125 mg.kg  -1 Cy s.c. 7 d later, the 
spleen cells of these animals and of controls  were cultured with either DS (50 #g.m1-1)  or LPS 25 
/zg. ml-l). Spleen cells of Cy-pretreated mice were mixed with various numbers of syngeneic  4HP- 
Cy-pretreated thymocytes (10  7 thymocytes incubated with 0.3 p,g.m1-1 4H-Cy for 1 h at 37°C and 
washed twice with medium) or control thymocytes (incubated for  1 h with medium) in presence 
and absence of DS or LPS. After 2 d, the cultures were pulsed for 4 h with [SH]Tdr and the [aH]Tdr 
uptake determined as described  in Material and Methods. The results are expressed  as A counts/ 
minute per culture. Each value represents  the arithmetic mean of A counts per minute detected in 
three individual cultures; se: <10%.  sc, spleen  cells; thy, thymocytes;  (Or) DS response  of normal 
spleen  cells;  ('k)  LPS respnse of normal spleen cells;  (0)  DS response of spleen cells derived from 
Cy-injected mice cultured alone or mixed with thymocytes;  (A) LPS response of spleen cells derived 
from Cy-injected mice cultured alone or mixed with thymocytes;  (O) DS response  of spleen  cells 
derived from Cy-injected mice cuhured  with 4HP-Cy-treated thymocytes;  (A)  LPS  response  of 
spleen cells derived from Cy-injected mice cultured with 4HP-Cy-treated thymocytes. 
In  this  work,  we  have  evaluated  the  mitogenic  response  in  vitro  of spleen  cells 
derived  from  either Cy-pretreated  mice or of spleen cells of normal  mice treated  in 
vitro with 4HP-Cy. 
Treatment  of mice with  125 rag. kg  -1 Cy results in a  drastic depletion of the spleen 
of both  B  and  T  lymphocytes.  7  d  after  this  treatment,  the  mice  immunized  with 
sheep  erythrocytes  gave  a  normal  or  even  a  slightly  enhanced  plaque-forming  cell 
response,  indicating recovery of the capacity of spleen cells to give humoral  immune 
responses  (data not shown). 
Spleen  cells derived  from  the  same  Cy-pretreated  mice show,  however,  dramatic 1574  DIAMANTSTEIN ET  AL.  BRIEF DEFINITIVE REPORT 
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F,o.  2.  Dose-dependent  alterations  (enhancement  and  suppression)  of the  DS  response  and 
suppression of the LPS response by 4HP-Cy treatment of spleen cells. (C57BL ×  DBA2)F1 spleen 
cells (10  7, m1-1) suspended in serum-free medium were incubated for 1 h at 37°C with various doses 
of 4HP-Cy. The cells were then washed twice with medium  and incubated (2 ×  106 cells.m1-1) 
with either DS (50 ~tg.  m1-1) or LPS (25/~g. ml  -~) for 2 (A) or for 4 d (B). The [3H]Tdr uptake was 
then determined  as described in Material and Methods. The results are expressed as percentage of 
the mitogenic response of the 4HP-Cy-treated ceils as compared to nontreated control cells =  100%. 
The values represent the mean of the three individual experiments, each performed in triplicates. 
The SE are shown by the vertical bars. (0) Cells cultured with DS; (A) cells cultured with LPS. 
changes  in  their  capacity to  respond  to  two  different  B-cell mitogens  (Fig.  1).  As 
compared  to  controls,  the  response  was  enhanced  to  DS  (up  to  eightfold)  and 
diminished to LPS  (up to 50%). The response of the cells to Con A  was unchanged. 
Five individual experiments gave essentially identical results. 
If  one accepts the concept that DS and LPS act on different subsets of B lymphocytes 
(11), one of the possible explanations of this phenomenon could be that after damage 
of the spleen by Cy, less-mature DS-reactive B cells may repopulate the spleen earlier 
than  more-mature  LPS-reactive B  ceils. Alternatively, both  types of B  lymphocytes 
should be sensitive to Cy, but  in contrast  to the LPS-reactive cells, the DS-reactive 
cells should  be  under  the  negative  control  of Cy-sensitive suppressor  cells.  These 
suppressor cells (T-suppressor ceils?) should  be more sensitive to Cy  action than  B 
lymphocytes and may repopulate the spleen later than the DS-reactive and the LPS- 
reactive cells. If so, the net effect of Cy treatment would be an enhanced response to 
DS and a  diminished response to LPS. 
The addition of graded number of thymocytes decreases the enhanced response of 
the cells to DS, but even slightly enhanced the response of the cells to LPS  (Fig.  1). 
Pretreatment of the thymocytes with presumably nontoxic doses of 4HP-Cy (1 ~tg per 
107 cells) abrogated the capacity of thymocytes to suppress the enhanced DS response 
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TABLE  I 
Diminished Mitogenic Response to DS and to LPS by 4HP-Cy Using T-Cell-depleted Spleen Cells 
Source of spleen cells  4HP-Cy 
treatment 
Mitogenic response  to 
DS  LPS  Con A 
BALB/c 
Anti-Thy-l.2 +  C-treated 
BALB/c 
Athymic (BALB/c) nude 
-  825 (4)  4,553 (22)  9,070  (43) 
+  5,050 (16)  1,250 (4)  9,500  (25) 
-  2,660 (11)  4,320  (15)  NS 
+  970 (4)  1,170 (4)  NS 
-  2,920 (12)  3,760 (16)  NS 
+  780 (3)  910 (4)  NS 
2 ×  10S.ml -a spleen cells or spleen  cells pretreated with anti-Thy-l.2 serum and C or spleen  cells of nude mice 
were incubated with 0.3/xg.m1-1 of 4HP-Cy for 1 h, washed two times, and cultured with 50 #g-m1-1 LPS or 2 
#g.m1-1 Con  A  for 4  d.  Each  value represents the arithmetic mean of [SH]Tdr uptake detected in  triplicate 
cultures. The results  are expressed  as A counts/minute per culture. Stimulation indices  (s.i.) are in parentheses. 
The discrepancies between  A counts  per  minute and  s.i. show  the  (up  to  threefold)  enhanced background 
proliferation of the BALB/c cells as a result  of 4HP-Cy treatment detectable in the majority of the experiments 
(6 out of 7). NS, no significant  A counts per minute cpm could be detected. 
These results  indicated,  but  did  not  directly prove the  negative control by Cy- 
sensitive T  lymphocytes on the proliferation of the DS-reactive B-lymphocyte subset. 
Experiments performed in vitro using 4HP-Cy--an in vitro active derivative of Cy-- 
clearly demonstrate the validity of this suggestion. 
Spleen cells of normal  mice pretreated with  small  doses of 4HP-Cy showed  an 
enhanced response to DS, whereas pretreatment of tl~ cells with high doses of this 
drug diminished the response of the cells to DS. In contrast, the LPS-reactivity of the 
cells was either unchanged or diminished by small and drastically diminished by high 
doses of 4HP-Cy (Fig. 2). 
If one assumes the inactivation by 4HP-Cy of T-suppressor cells is responsible for 
the enhanced  DS  response, no such effects should  be detectable using spleen cells 
depleted ofT cells or lacking functionally active T  cells. As shown previously (8), and 
as seen in Table I, anti-theta serum-and-C-treated spleen cells or spleen ceils of nude 
mice give a higher response to DS than normal spleen cells. The LPS reactivity was 
unchanged. As expected, the response to DS and to LPS was diminished by treatment 
of T-cell-depleted spleen cells with 4HP-Cy. The same dose of 4HP-Cy enhanced the 
response of normal spleen cells to DS. In addition, these results ruled out the possibility 
of a  selective and direct potentionating effect of Cy, or of its active metabolites on 
DS-reactive B ceils. 
In conclusion, our results demonstrate directly (a) that lymphocytes can generally 
be functionally inactivated by Cy or by its active metabolites, (b) that, as expected 
from indirect in vivo experiments, T-suppressor cells  (or their precursors) are more 
sensitive to Cy than B lymphocytes, and (c) suggest that the DS-reactive, but not the 
LPS-reactive, B-lymphocyte subset  is under the negative control of T  lymphocytes. 
Summary 
As measured by [SH]thymidine uptake, spleen cells of mice injected 7 d previously 
with  a  single  dose  of cyclophosphamide  (Cy)  (125  mg.kg  -1)  gave  an  enhanced 
response to dextran sulfate (DS), a diminished response to lipopolysaccharide (LPS), 
and a normal response to concanavalin A. Addition of syngeneic thymocytes to spleen 
cells inhibited the enhanced response of the cells to DS and slightly enhanced their 1576  DIAMANTSTEIN  ET AL.  BRIEF  DEFINITIVE REPORT 
response to LPS. Pretreatment  of thymocytes by 4-hydroxyperoxycyclophosphamide 
(4HP-Cy)  in  vitro  (an  in  vitro  active  derivative  of Cy)  abrogated  the  effect  of 
thymocytes on the DS response but not on the LPS response. Pretreatment  of spleen 
cells by small  doses of 4HP-Cy  (0.1-1.0/~g. m1-1)  in vitro enhanced the capacity of 
the cells to respond to DS but either did not affect, or even diminished their capacity 
to respond to LPS. The enhancement of the DS response by 4HP-Cy treatment could 
not be detected using spleen  cells depleted  of T  cells or lacking functioning T  cells. 
4HP-Cy doses >3 btg" ml -I diminished or abolished the capacity of the spleen cells to 
respond to LPS as well as their capacity to respond to DS. 
The results show (a)  that in contrast to the LPS-reactive B-lymphocyte subset, the 
proliferative  capacity  of DS-reactive  subset  is  negatively  controlled  by  a  Cy-  and 
4HP-Cy-sensitive T-cell subset and (b) that these T-suppressor cells are more sensitive 
to Cy and 4HP-Cy (to their respective active alkylating metabolites)  than B lympho- 
cytes and T  cells carrying other immunological functions. 
The  excellent  technical  assistance  of Maria  V.  Odenwald  and  Gisela  Schulz  is  gratefully 
acknowledged. 
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